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Abstract
Background: Infancy and childhood are characterized by rapid growth and development, which largely determine
health status and well-being across the lifespan. Identification of modifiable risk factors and prognostic factors in
critical periods of life will contribute to the development of effective prevention and intervention strategies.
The LucKi Birth Cohort Study was designed and started in 2006 to follow children from birth into adulthood on a
wide range of determinants, disorders, and diseases. During preschool and school years, the primary focus is on the
etiology and prognosis of atopic diseases (eczema, asthma, and hay fever) and overweight/obesity.
Methods/Design: LucKi is an ongoing, dynamic, prospective birth cohort study, embedded in the Child and Youth
Health Care (CYHC) practice of the ‘Westelijke Mijnstreek’ (a region in the southeast of the Netherlands). Recruitment
(1–2 weeks after birth) and follow-up (until 19 years) coincide with routine CYHC contact moments, during which the
child’s physical and psychosocial development is closely monitored, and anthropometrics are measured repeatedly in a
standardised way. Information gathered through CYHC is complemented with repeated parental questionnaires, and
information from existing registries of pharmacy, hospital and/or general practice. Since the start already more than
5,000 children were included in LucKi shortly after birth, reaching an average participation rate of ~65 %.
Discussion: The LucKi Birth Cohort Study provides a framework in which children are followed from birth into
adulthood. Embedding LucKi in CYHC simplifies implementation, leads to low maintenance costs and high
participation rates, and facilitates direct implementation of study results into CYHC practice. Furthermore, LucKi
provides opportunities to initiate new (experimental) studies and/or to establish biobanking in (part of) the
cohort, and contributes relevant information on determinants and health outcomes to policy and decision
makers. Cohort details can be found on www.birthcohorts.net.
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Background
Infancy and childhood are characterised by rapid growth
and development, and are considered critical developmen-
tal periods in life that strongly contribute to health status,
well-being, and behaviour across the lifespan [1]. In fact,
many common diseases and challenges in adult life can be
traced back to early childhood [2]. Because growth and
development in early life are highly influenced by the
child’s environment, identification of modifiable risk fac-
tors (e.g. in lifestyle, and physical and social environment)
forms the basis for the development of preventive mea-
sures for childhood and adult diseases.
The LucKi Birth Cohort Study was designed and started
in 2006 to follow children from birth into adulthood.
Within LucKi, information on a wide range of determi-
nants and outcomes is gathered in order to answer etio-
logical questions and to identify prognostic factors and
modifiable risk factors for various childhood and adult
diseases and conditions. In time, the LucKi cohort will be
large enough to enable new (intervention) studies within
part of the study population. Ultimately, the LucKi data-
base will contain relevant information on childhood and
adulthood well-being, health and disease that can help
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researchers, clinicians, and policy makers to develop and
implement prevention and intervention measures.
In preschool and early school age, the primary focus
of LucKi is on atopic diseases (eczema, asthma, and hay
fever) and overweight/obesity. Atopic diseases are
among the most prevalent chronic disorders in child-
hood and their prevalence is still increasing in many
developed countries [3, 4]. While some children out-
grow their complaints with increasing age, others per-
sist to suffer from atopic diseases into adulthood [5].
Also, childhood overweight and obesity are becoming
increasingly prevalent chronic disorders in developed
societies [6], and increase the risk of long-term adverse
conditions, including cardiovascular, metabolic, pul-
monary, and gastrointestinal diseases [7]. It is still
largely unknown what factors are involved in the aeti-
ology and/or are responsible for the progression of
atopic diseases, and there is even less knowledge on
how atopic diseases and overweight/obesity can be pre-
vented or treated. This knowledge is essential for devel-
oping effective prevention and intervention strategies
and testing these in a real-life setting. Therefore, within
LucKi, the main objectives are to 1) to estimate the contri-
bution and timing of known risk factors, and 2) to identify
and evaluate new risk factors for atopic diseases and over-
weight/obesity. The latter requires add-on modules (e.g.
questionnaires, measurements, biosampling) to the exist-
ing LucKi infrastructure that specifically target potential
new risk factors.
Suffering from atopic diseases, overweight or obes-
ity, or other adverse conditions in childhood, as well
as acquiring certain lifestyle patterns early in life, may
have lifelong consequences. Therefore, in older chil-
dren and adolescents also other outcomes will be
studied, for example social functioning, and behav-
ioural and mental health conditions.
This paper describes the design of the LucKi Birth
Cohort study, presents baseline characteristics and
prevalence of atopic diseases and overweight in part of
the study population, and discusses strengths and limi-
tations of the study.
Methods/Design
Study design
LucKi is an ongoing, dynamic, prospective birth cohort
study. Since the start in 2006, newborns are continu-
ously being included into the study and will be followed
prospectively until at least the age of 19 years. Given the
ongoing character of the study, no end date or max-
imum number of inclusions has been set. Cohort details
can also be found on www.birthcohorts.net.
Setting
LucKi is embedded in the Child and Youth Health Care
practice of the Westelijke Mijnstreek in the Netherlands.
The Westelijke Mijnstreek (Fig. 1) is a region in the
Province of Limburg in the south east of the Netherlands
that encompasses four municipalities: Sittard-Geleen, Stein,
Beek, and Schinnen, with a total area of ~150 km2 (~58
square miles). This former coal-mining region is now char-
acterized by a high building density, a relatively dense
transport infrastructure, and car and chemical industry.
Fig. 1 Location of the study area ‘Westelijke Mijnstreek’ in the Netherlands
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These characteristics, further strengthened by adjacent
foreign industrial areas, result in relatively high concen-
trations of air pollutants, such as nitric oxide and nitro-
gen dioxide [8].
Due to ageing of the population, the number of inhab-
itants has been gradually decreasing since the late 1990s.
In 2006 the total population size of the Westelijke
Mijnstreek was ~154,000; in 2013 there were ~149,000 in-
habitants. The large majority (97 %) of inhabitants of the
Westelijke Mijnstreek are of Dutch nationality, but 19 %
of inhabitants are first or second generation immigrants.
Although these figures are comparable to national average
(96 and 21 %, respectively), in the Westelijke Mijnstreek
more immigrants originate from western countries (75 %)
than from non-western countries (25 %), while in the
whole of the Netherlands this ratio is 45 versus 55 %. Fur-
thermore, compared to the national average, inhabitants
of the Westelijke Mijnstreek have a slightly lower educa-
tional and income level, but unemployment rates are com-
parable. Table 1 illustrates that the prevalence of certain
health and life style characteristics, such as overweight
and obesity and respiratory diseases is relatively high in
this part of the Netherlands [9].
Dutch child and youth health care system
Child and Youth Health Care (CYHC) in the Netherlands
is obliged by law to promote and protect the health and
physical, cognitive and psychosocial development of chil-
dren between 0 and 19 years of age, and to carry out the
national immunisation program. To achieve these goals,
children are followed prospectively from birth.
All children living in the Netherlands and their parents
or caregivers are invited regularly for a routine physical
and developmental check-up. A team consisting of physi-
cians, nurses, and assistants routinely check the child’s
growth and development, and provide parents with re-
quested and unrequested support and advice. The first
contact with CYHC (when the child is 1–2 weeks old)
takes place at home; all other contact moments take place
at CYHC-centres. The frequency of routine contact mo-
ments decreases with age (see Table 2), but if necessary,
children are invited more often to visit CYHC, e.g. when
growth is impaired or there are other concerns. In case
of suspicion of diseases or disorders, the child is re-
ferred to a general practitioner or medical specialist. In
general, ~90 % of all parents visit CYHC with their
children regularly. The last planned visit takes place when
the child is 14 or 15 years old. Children between 16 and
19 years are only invited for an extra check-up visit if their
physical or social development raises concerns.
All relevant information is kept in a personal digital
file in the CYHC registry. After the child reaches the age
of 19 years, the file is no longer updated, but is kept for
another 15 years in the registry.
Study population
The study population of the LucKi Birth Cohort study
consists of all children born since July 2006 who live in
the study area and whose parents agree to participate.
Recruitment
Recruitment of the newborns and their parents takes place
during the routine home visit by a CYHC-nurse, when the
baby is 1–2 weeks old. Purposes of this home visit include
to get acquainted with the parents and introduce them to
CYHC procedures, and to perform the neonatal heel
prick. CYHC receives a notification of an infants’ birth in
their region as soon as the parents have registered the
newborn child at the municipal office. This registration is
obligatory in the Netherlands and has to take place within
3 days after birth. Upon notification CYHC contacts the
parents to plan a home visit. Parents receive oral and writ-
ten information about the purpose and methods of the
study and are invited to participate. If parents agree to
Table 1 Health and lifestyle characteristics of inhabitants (between 19 and 65 years of age) of the Westelijke Mijnstreek and the
whole of the Netherlands
Westelijke Mijnstreek the Netherlands
Perceived health: good/very good 77.7 % 80.7 %
High blood pressure 14.5 % 12.6 %
Chronic respiratory complaints 9.5 % 7.8 %
Diabetes Mellitus 4.6 % 3.6 %
Never drinks alcohol 15.8 % 16.5 %
Heavy alcohol use 12.7 % 11.6 %
Smoker 25.5 % 25.5 %
Heavy smoker 5.5 % 4.7 %
Overweight (incl. obese) 48.5 % 45.5 %
Obese 13.3 % 11.8 %
Data over the year 2012, standardised for age and sex. Data obtained from regional Public Health Services (GGD), Statistics Netherlands (CBS), and the National
Institute for Public Health and the Environment (RIVM)
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participate, they are asked to sign informed consent for
the use of data from the CYHC registry, pharmacy, hos-
pital and/or general practice.
Parents of children who are not included/invited to par-
ticipate at birth, but visit CYHC from a later age onwards
(e.g. because they move into the study area), are also in-
vited to participate in LucKi from the moment they first
visit CYHC in the study area.
In- and exclusion criteria
The only inclusion criterion for participating in LucKi is
living in the study area. Children whose parents never
visit CYHC are excluded.
Data collection
Data collection takes place through repeated parental
questionnaires and is complemented with information
Table 2 Number of planned contact moments with Child and Youth Health Care (CYCH), number of LucKi questionnaires, and main
(research) topics in different age periods
0-1 1-4 4-12 12-19
years years years years
Number of routine contact moments CYHC 9 5 3 2
Number of LucKi questionnaires 2 2 2 1
Main topics CYHC
General physical examination ++ ++ ++ ++
Growtha ++ ++ ++ ++
Overweight & obesity + + + +
Pre-/peri-/postnatal complications ++
Family history of diseases/disorders ++
(Mal) nutrition ++ ++ + +
Vision & hearing + + + +
Motor developmentb + ++ + +
Language development + ++
Social class & family functioning ++ ++ ++ +
Emotional & social development + ++ ++ +
Learning disabilities ++ +
Behavioural problems + + +
Child abuse & neglect ++ ++ ++ +
Addiction + ++
Main topics LucKi questionnaires
Parental medical history +
Circumstances around pregnancy & birth ++
Parental lifestyle characteristics ++ +
Eczema, wheeze/asthma, hay feverc ++ ++ ++ ++
Infections, diarrhoea, fever ++ ++ + +
Other diseases + + ++ ++
Medication use + + + +
Diet ++ ++ ++ ++
Physical activity + + +
Day care attendance + +
Indoor environment + + + +
Outdoor environment + +
School absence + +
++ high level of interest; + routine level of interest
a Standardised height, weight, and head or waist circumference measurements by trained personnel at each visit
b Van Wiechen classification of psychomotor development [13]
c ISAAC (the International Study of Asthma and Allergies in Childhood) core questions [10]
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from the CYHC registry, pharmacist, hospital and/or gen-
eral practitioner, provided informed consent to do so is
given by the parents. The timing of the questionnaires co-
incides with routine contact moments in CYHC.
Baseline questionnaire
At baseline (1–2 weeks after birth), parents are asked to
complete a questionnaire that includes questions on par-
ental medical history, parental characteristics and lifestyle,
indoor and outdoor environment, and circumstances dur-
ing pregnancy and around birth (Table 2).
Follow-up questionnaires
When the child is 6/7 months, 14 months, 3 years, and
5/6 years old, parents are asked to complete a follow-
up questionnaire for their child. Further follow-up
questionnaires are being planned for ages 10/11 and
14/15 years. Follow-up questionnaires include ques-
tions on atopic diseases, infections, lifestyle, diet, phys-
ical activity, indoor and outdoor environment, medication
use, health care utilisation, and school absence (Table 2).
Questions on atopic diseases are based on the validated
ISAAC (The International Study of Asthma and Allergies
in Childhood) questionnaire [10], a questionnaire that is
widely used in (monitor) studies on childhood asthma,
allergic rhinitis, and eczema.
Child and Youth Health Care (CYHC) registry
During the CYHC home-visit at 1–2 weeks of age an
individual digital file is set up with information on par-
ental background (e.g. ethnicity, education, work status,
family and medical history) and circumstances during
pregnancy and birth (e.g. pre-pregnancy weight, gesta-
tional age at birth, mode and place of delivery) derived
from midwife’s and/or obstetrician’s reports. This file is
complemented with new information after every subse-
quent visit to CYHC.
At each visit a nurse assistant measures the child’s
height and weight in a standardised way. Weight is mea-
sured on a digital baby scale (birth until 18 months, in a
lying or sitting position without clothes) or a digital flat
scale (18 months and older, in a standing position wearing
only underpants or diaper). Height is measured using an
infantometer (birth until 18 months, in a lying position)
or a microtoise (18 months and older, in a standing pos-
ition). Scales and microtoise are calibrated yearly and after
translocation.
Other important information that is inquired during
CYHC visits and registered in the digital file includes the
child’s nutritional status and physical and psychosocial de-
velopment (Table 2).
Pharmacy, hospital, and general practice registries
If additional information on prescribed medication, doc-
tor’s diagnosis, or treatment for various conditions and
diseases is needed to answer a specific research question,
the variables of interest will be obtained from pharmacy,
hospital or general practice registries, provided parents
gave informed consent to do so.
Ethical clearance
The LucKi Birth Cohort Study was approved by the
Medical Ethical Committee of Maastricht University
Medical Centre (MEC 09–4–058). LucKi is designed ac-
cording to the privacy rules that are stipulated in the
Dutch ‘Code of Conduct for Health Research’ [11].
Preliminary cohort description
Inclusion of newborns and follow-up of LucKi participants
is still ongoing. Since the start in 2006, already more than
5,000 children were included in LucKi shortly after birth,
reaching an average participation rate of ~65 %. Most par-
ents completed one or more of the follow-up question-
naires (> 75 %), and gave informed consent to use date
from other registries (> 80 %).
Table 3 provides baseline characteristics of children that
were included in LucKi between July 2006 and December
2011, and presents the prevalence of eczema, wheeze and
overweight in these children.
Discussion
In this paper we presented the rationale and design of the
LucKi Birth Cohort Study. Within LucKi, children are
followed prospectively from birth into adulthood through
repeated questionnaires and routine registries, with, dur-
ing preschool and school years, a primary focus on the de-
velopment of atopic diseases and overweight.
Strengths and limitations
LucKi is entirely embedded in regular Child and Youth
Health Care (CYHC) practice and is linked to other regis-
tries, which has certain advantages. First, because recruit-
ment and follow-up coincide with routine contact
moments, high participation and follow-up rates are en-
sured. Second, maintenance costs and time investment
are relatively low, permitting continuous inclusion of new
participants into LucKi. This results in several (birth year)
groups within the cohort, some of which may serve as
study population for future experimental studies. Third,
the continuous character of the study allows us to adapt
or supplement the data collection methods according to
new insights in the field or to harmonise with other birth
cohort studies. Preferably, LucKi measurements will be
extended with the collection of biomaterial in the future.
Fourth, because information is gathered through different
sources, data entries can be cross-checked for a large
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number of variables, which strengthens the reliability of
the data. And fifth, since CYHC has direct access to a
large number of children and at different ages, study re-
sults of LucKi may be directly implemented into CYHC
practice. Other important strengths of LucKi are the lon-
gitudinal design, which allows investigating temporal and
causal relationships, and the availability of repeatedly mea-
sured weight and height data. The latter eliminates bias
associated with self-reporting (e.g. social desirability bias
and recall bias), which is a well-known limitation in many
population studies on overweight and obesity [12].
A limitation to LucKi (as to any observational study) is
the possibility of selection in the study population. Al-
though LucKi reaches relatively high participation rates, a
reason for not participating may be not speaking the
Dutch language and therefore not being able to complete
the questionnaires. Also, parents of children who are hos-
pitalised or under intensive paediatric treatment may not
attend the CYHC regularly, and in general parents of
higher socio-economic status are more likely to participate
in such a study. Descriptive data from the regional Public
Health Service will enable comparison of responders and
non-responders on several characteristics, the results of
which will be reported in future research papers. Although
any selection may affect estimated prevalence rates, and
therefore also the statistical power and generalizability of
study results, it will most likely not bias etiological associ-
ations. Furthermore, although CYHC only has access to
the children after birth, information on important prenatal
factors are covered in the baseline questionnaire.
Application of study results
The information gathered by the LucKi Birth Cohort
Study is valuable for (youth) health care and public health
policy. Because children are studied at specific ages that
coincide with CYHC contact moments, findings from
LucKi that can be translated into parental advice or other
preventive measures may directly be incorporated in
CYHC protocols and reach a large group of children and
their parents at once. Further, study results on (modifi-
able) risk factors, disease prognosis, and medication use
may also be relevant for general practitioners and
pharmacists.
Moreover, LucKi’s findings may aid policy and decision
makers, who need scientific evidence to develop and im-
plement prevention and intervention strategies. LucKi
progressively builds on a database containing policy rele-
vant information on a broad range of determinants and
health outcomes that may be beneficial to response to
current and future public health issues. Furthermore,
LucKi results may contribute to the evidence built up by
several international birth cohorts and to the development
of guidelines. Collaboration between birth cohorts is
Table 3 Baseline characteristics of LucKi participants born
between July 2006 and December 2011
N = 4.230
Sex (% male) 50.2 %
Gestational age at birtha
• < 37 weeks 5.8 %
• 37–40 weeks 70.7 %
• > 40 weeks 22.9 %
Maternal smoking during pregnancy 10.5 %
Breastfeeding (exclusive or combined)
• until age 3 months 35.4 %
• until age 6 months 16.9 %
Parental history of atopyb 57.0 %
Number of older siblingsa
• 0 43.2 %
• 1 38.3 %
• > 1 11.9 %
Day care attendancec 55.2 %
Pet keepingd 51.4 %
Eczema prevalencee
Age 7 months 14.7 %
Age 14 months 13.3 %
Age 3 years 16.2 %
Wheeze prevalencee
Age 7 months 16.4 %
Age 14 months 18.3 %
Age 3 years 13.0 %
Overweight prevalencef
Age 3 years 7.6 %
a Due to missing values, percentages do not add up to 100 %
b Defined as mother or father ever having asthma, hay fever, or eczema
c Defined as visiting day care weekly at age 7 months of age
d Defined as ≥ 1 pets in the home at baseline (1–2 weeks of age)
e The prevalence of eczema and wheeze is based on parentally reported
symptoms through validated ISAAC questionnaires [10]
f The prevalence of overweight was calculated with age- and sex-specific cut-
off points for Body Mass Index of a widely used international standard [14]
Table 4 Summary of the aims of the LucKi Birth Cohort Study
LucKi’s aims in preschool- and early school-age:
1) to study the aetiology and the prognosis of atopic diseases and
overweight/obesity
2) to identify modifiable risk factors for atopic diseases and
overweight/obesity
Long (er)-term aims of LucKi:
3) to study the long-term consequences of early life exposures and
acquired lifestyle patterns
4) to constitute a scientific framework for initialising new
(intervention) studies
5) to build a database containing information on childhood and
adulthood well-being and diseases that is relevant to researchers,
clinicians and policy makers
Korte-de Boer et al. BMC Public Health  (2015) 15:934 Page 6 of 7
especially important to achieve more variation in exposure
variables, and in that context, LucKi can contribute with
research data from children living in a relatively unfavour-
able outdoor environment.
Summary (see also Table 4)
To summarise, children in the LucKi Birth Cohort Study
are prospectively followed from birth in order to gain
more insight into risk factors for atopic diseases and over-
weight development. The aims of LucKi are summarised
in Table 4. Because of the ongoing, dynamic character,
LucKi can be seen as a scientific framework that provides
opportunities to initiate new (experimental) studies and/
or to establish biobanking in (parts of) the cohort, and
may as well contribute relevant information on determi-
nants and health outcomes to health care professionals,
and policy and decision makers.
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